<DOC>
	<DOCNO>NCT01874886</DOCNO>
	<brief_summary>Marijuana ( Cannabis sativa ) widely use illicit drug worldwide , 17.4 million Americans report past month use 2010 4.6 million meeting criterion dependence , underscore public health importance understand biological implication use . How heavy cannabis use affect brain structure cognitive performance late life unknown . The ongoing maturation adolescent brain , include developmental circuitry underlie memory performance executive control put adolescent brain high risk detrimental effect heavy cannabis use . With age 'baby boomer ' generation , many people use cannabis heavily adolescent enter senior year age-related cognitive decline may begin . Cannabis use double less decade 1970 's 38 % survey U.S. Survey Drug Abuse report use cannabis 12 % user report use cannabis 20 time month . Understanding heavy , early cannabis use may affect neurobiological cognitive outcome high importance age population , already risk memory cognitive deficit age . Because cannabis use appear primary effect within hippocampus , main structure memory structure affect age-related memory impairment pre-clinical Alzheimer 's disease , expect effect chronic cannabis use may greatest age . To knowledge , study investigate long-term effect adolescent cannabis use hippocampal morphology cognitive performance age population . Investigators investigate hippocampal integrity cognitive performance use high-resolution magnetic resonance imaging ( MRI ) , diffusion tensor imaging ( DTI ) neuropsychological test age population subject ( 55-70 year old ) use cannabis 20 time month least year adolescence . Investigators compare data collect heavy cannabis user subject use cannabis match age , gender , education , light tobacco light alcohol use . Finally , family history genetic risk know accelerate hippocampal morphology memory decline aging , investigator investigate whether possession APOE Îµ4 variant heavy cannabis user synergistically related thinner hippocampal cortex white matter deficit .</brief_summary>
	<brief_title>Cannabis Effects Brain Morphology Aging</brief_title>
	<detailed_description />
	<mesh_term>Marijuana Abuse</mesh_term>
	<criteria>Inclusion Criteria Subjects 60 heavy user nonusers 6080 year age Participants use marijuana adolescence . Current marijuana usage allow subject must complete urine screening time inclusion . Exclusion Criteria Major psychiatric disorder , bipolar disorder schizophrenia reveal Structured Clinical Interview DSMIV Disorders ( 100 ) exclude confound psychiatric condition Evidence untreated depression determine HAMD Score &gt; 12 ( 17item version ) untreated anxiety score &gt; 8 Hamilton Anxiety Scale Evidence neurologic physical illness could produce cognitive deterioration . Volunteers history TIAs , carotid bruits , lacunae MRI scan exclude History myocardial infarction within previous year unstable cardiac disease Uncontrolled hypertension ( systolic BP &gt; 170 diastolic BP &gt; 100 ) History significant liver disease Clinically significant pulmonary disease , diabetes , cancer Because medication affect cognitive functioning , subject needing medicine could influence psychometric test result exclude . These include : centrally active betablockers , narcotic , clonidine , antiParkinsonian medication , systemic corticosteroid , benzodiazepine , medication significant cholinergic anticholinergic effect , anticonvulsant , warfarin , affect serotonin system , may affect neuropsychological test result . Current diagnosis history alcoholism dependence illicit drug marijuana . Use investigational drug within previous month longer , depend drug halflife . Contraindication MRI scan ( e.g . metal body , claustrophobia ) .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Magnetic resonance imaging</keyword>
	<keyword>Diffusion tensor image</keyword>
	<keyword>Hippocampus</keyword>
	<keyword>Cannabis</keyword>
	<keyword>Geriatrics</keyword>
	<keyword>Neuropsychology</keyword>
	<keyword>Apolipoprotein E</keyword>
</DOC>